We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
We work for a secure and prosperous United Kingdom with global reach and influence. We will protect our people, territories, values and interests at home and overseas, through strong armed forces and in partnership with allies, to ensure our security,...
Guidance on using the tax system to offer gym memberships and sports facilities to staff.
Check the tariff classification for articles and equipment for general physical exercise and other sports or outdoor games.
Guidance on Conditional Marketing Authorisations, exceptional circumstances Marketing Authorisations and national scientific advice
Progress update explaining the process for rationalising output and outcome monitoring indicators for future funding.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine rozanolixizumab (Rystiggo) to treat adults with generalised myasthenia gravis, an autoimmune disease that causes muscle weakness, which can affect multiple muscle groups throughout the...
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Find out how you could do the SFI actions for low input grassland.
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
The Multi-Sport Grassroots Facilities Programme is investing over £320 million to level up sports facilities across the UK.
Details of the process changes for established medicines, effective from 1 March 2024, which apply specifically to chemical products.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
Guidance on the national tuberculosis (TB) strain typing service, including its work, achievements, objectives, and future direction.
A foreword on the Department for Levelling Up, Housing and Communities’ commitment to the evaluation of local growth programmes.
The Department for Culture, Media and Sport supports culture, arts, media, sport, tourism and civil society across every part of England — recognising the UK’s world-leading position in these areas and the importance of these sectors in contributing so much...
The Multidisciplinary University Research Initiative (MURI) is a US Department of Defense (DoD) programme.
UK Anti-Doping (UKAD) implements and manages anti-doping policy in the UK. It works with athletes and national sports bodies to ensure compliance with the World Anti-Doping (WADA) Code. UKAD is an executive non-departmental public body, sponsored by the Department for...
A form of IP that extends the protection of patented active ingredients present in pharmaceutical or plant protection products.
Information about in-year growth funding for 2023 to 2024.
Details of 7 quality markers for strength and balance exercise, suitable for use by local areas as criteria to help them carry out self-audits.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.